Nisa Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,890
| Closed | -$141K | – | 2869 |
|
|
2023
Q1 | $141K | Buy |
15,890
+774
| +5% | +$6.87K | ﹤0.01% | 1389 |
|
|
2022
Q4 | $138K | Sell |
15,116
-10,712
| -41% | -$97.8K | ﹤0.01% | 1455 |
|
|
2022
Q3 | $208K | Sell |
25,828
-96,023
| -79% | -$773K | ﹤0.01% | 1264 |
|
|
2022
Q2 | $916K | Buy |
121,851
+35,968
| +42% | +$270K | 0.01% | 850 |
|
|
2022
Q1 | $806K | Sell |
85,883
-8,252
| -9% | -$77.4K | 0.01% | 941 |
|
|
2021
Q4 | $794K | Buy |
+94,135
| New | +$794K | 0.01% | 895 |
|
|
2021
Q2 | – | Sell |
-23,340
| Closed | -$269 | – | 2384 |
|
|
2021
Q1 | $269 | Buy |
+23,340
| New | +$269 | ﹤0.01% | 1383 |
|
|
2020
Q3 | – | Sell |
-74,443
| Closed | -$918K | – | 2266 |
|
|
2020
Q2 | $918K | Buy |
+74,443
| New | +$918K | 0.01% | 814 |
|
|
2019
Q3 | – | Sell |
-126
| Closed | -$1K | – | 2045 |
|
|
2019
Q2 | $1K | Sell |
126
-247
| -66% | -$1.96K | ﹤0.01% | 2008 |
|
|
2019
Q1 | $6K | Sell |
373
-19,020
| -98% | -$306K | ﹤0.01% | 1878 |
|
|
2018
Q4 | $299K | Sell |
19,393
-3,900
| -17% | -$60.1K | ﹤0.01% | 1137 |
|
|
2018
Q3 | $504K | Buy |
23,293
+22,920
| +6,145% | +$496K | ﹤0.01% | 1091 |
|
|
2018
Q2 | $11K | Sell |
373
-101
| -21% | -$2.98K | ﹤0.01% | 1712 |
|
|
2018
Q1 | $13K | Hold |
474
| – | – | ﹤0.01% | 1579 |
|
|
2017
Q4 | $13K | Hold |
474
| – | – | ﹤0.01% | 1680 |
|
|
2017
Q3 | $14K | Buy |
474
+3
| +0.6% | +$89 | ﹤0.01% | 1643 |
|
|
2017
Q2 | $17K | Sell |
471
-206
| -30% | -$7.44K | ﹤0.01% | 1534 |
|
|
2017
Q1 | $25K | Hold |
677
| – | – | ﹤0.01% | 1477 |
|
|
2016
Q4 | $25K | Hold |
677
| – | – | ﹤0.01% | 1569 |
|
|
2016
Q3 | $31K | Sell |
677
-34
| -5% | -$1.56K | ﹤0.01% | 1509 |
|
|
2016
Q2 | $37K | Buy |
711
+88
| +14% | +$4.58K | ﹤0.01% | 1435 |
|
|
2016
Q1 | $33K | Buy |
+623
| New | +$33K | ﹤0.01% | 1457 |
|